- Praxis Precision Medicines Inc Extraordinary Shareholders Meeting TranscriptNov 06, 2023
- Praxis Precision Medicines Inc R&D Day TranscriptOct 02, 2023
- Praxis Precision Medicines Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Praxis Precision Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Praxis Precision Medicines Inc Essential1 Topline Results Call TranscriptMar 03, 2023
- Praxis Precision Medicines Inc at Citi Biopharma Co-Panel Day (Virtual) - Mood Disorders/Mental Health Panel TranscriptMay 18, 2022
- Praxis Precision Medicines Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Praxis Precision Medicines Inc Earnings Call TranscriptMay 09, 2022$110.85 (-8.54%)Earnings
- Praxis Precision Medicines Inc Epilepsy Day TranscriptApr 27, 2022
- Praxis Precision Medicines Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 Praxis Precision Medicines Inc Earnings Call TranscriptFeb 28, 2022$196.5 (-1.73%)Earnings
- Praxis Precision Medicines Inc Movement Disorder Day TranscriptDec 17, 2021
- Q3 2021 Praxis Precision Medicines Inc Earnings Call TranscriptNov 03, 2021$329.55 (+1.24%)Earnings
- Praxis Precision Medicines Inc at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
- Praxis Precision Medicines Inc Annual Shareholders Meeting TranscriptJun 08, 2021
- Q4 2020 Praxis Precision Medicines Inc Earnings Call TranscriptMar 17, 2021$637.65 (+2.56%)Earnings
Praxis Precision Medicines Inc at Citi Biopharma Co-Panel Day (Virtual) - Mood Disorders/Mental Health Panel Transcript
All right. Hi, everybody. Thank you for joining Citi's Virtual Company Panel Day. If you don't know me, my name is Neena Bitritto-Garg. I'm one of the biotech analysts here at Citi. And for our next panel, we'll be discussing Mood Disorders and Mental Health. And I'm really pleased to be joined by executives from 4 companies working in this space, including Atai Life Sciences, Bionomics, COMPASS Pathways and Praxis Precision Medicines. And before we do get into Q&A, I just wanted to flag that if you do have any questions, you can feel free to send me an e-mail directly. My e-mail address is listed on the webcast. You could find now on Bloomberg and ping me that way, whatever works for you.
So now I just wanted to turn it over to our panelists. And maybe if we go alphabetically by company names, so maybe, Srini, if you want to start, introduce yourself and give some opening remarks on Atai and then we can go around, yes, alphabetically by company name.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)